Federal Drug Strategy 1983

For nearly three decades, methadone hydrochloride has been the primary means of treating opiate addiction. Today, about 115,000 people receive such treatment, and thousands more have benefited from it in the past. Even though methadone's effectiveness has been well established, its use remains controversial, a fact reflected by the extensive regulation of its manufacturing, labeling, distribution, and use. The Food and Drug Administration regulates the safety and effectiveness of methadone, as it does for all drugs, and the Drug Enforcement Administration regulates it as a controlled substance. However, methadone is also subjected to a unique additional tier of regulation that prescribes how and under what circumstances it may be used to treat opiate addiction. Federal Regulation of Methadone Treatment examines current Department of Health and Human Services standards for narcotic addiction treatment and the regulation of methadone treatment programs pursuant to those standards. The book includes an evaluation of the effect of federal regulations on the provision of methadone treatment services and an exploration of options for modifying the regulations to allow optimal clinical practice. The volume also includes an assessment of alternatives to the existing regulations.

Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.

Treating Drug Problems, Volume 2 presents a wealth of incisive and accessible information on the issue of drug abuse and treatment in America. Several papers lay bare the relationship between drug treatment and other aspects of drug policy, including a powerful overview of twentieth century narcotics use in America and a unique account of how the federal government has built and managed the drug treatment system from the 1960s to the present. Two papers focus on the criminal justice system. The remaining papers focus on Employer policies and practices toward illegal drugs. Patterns and cycles of cocaine use in subcultures and the popular culture. Drug treatment from a marketing, supply-and-demand perspective, including an analysis of policy options. Treating Drug Problems, Volume 2 provides important information to policy makers and administrators, drug treatment specialists, and researchers.

How the drug war transformed American political culture Since the 1950s, the American war on drugs has positioned white middle-class youth as sympathetic victims of illegal drug markets who need rehabilitation instead of incarceration whenever they break the law. The Suburban Crisis traces how politicians, the media, and grassroots political activists crusaded to protect white families from perceived threats while criminalizing and incarcerating urban minorities, and how a troubling legacy of racial injustice continues to inform the war on drugs today. In this incisive political history, Matthew Lassiter shows how the category of the “white middle-class victim” has been as central to the politics and culture of the drug war as racial stereotypes like the “foreign trafficker,” “urban pusher,” and “predatory ghetto addict.” He describes how the futile mission to safeguard and control white suburban youth shaped the enactment of the nation’s first mandatory-minimum drug laws in the 1950s, and how soaring marijuana arrests of white Americans led to demands to refocus on “real criminals” in inner cities. The 1980s brought “just say no” moralizing in the white suburbs and militarized crackdowns in urban centers. The Suburban Crisis reveals how the escalating drug war merged punitive law enforcement and coercive public health into a discriminatory system for the social control of teenagers and young adults, and how liberal and conservative lawmakers alike pursued an agenda of racialized criminalization.